CURRENT ASSETS: |
Cash and cash equivalents |
526.6M |
Marketable securities |
Accounts receivable, net |
725.83M |
Inventories, net |
374.44M |
Prepaid expenses and other current assets |
39.4M |
Income taxes receivable |
0 |
Deferred income taxes |
257.99M |
Total current assets |
2.85B |
Equity securities, Carrying Amount |
2.98M |
PROPERTY, PLANT AND EQUIPMENT, NET |
372.08M |
GOODWILL |
1.37B |
OTHER INTANGIBLES, NET |
1.87B |
OTHER ASSETS |
96.54M |
TOTAL ASSETS |
6.57B |
CURRENT LIABILITIES: |
Accounts payable |
263.24M |
Accrued expenses |
979.96M |
Current portion of long-term debt, net |
414.93M |
Acquisition-related contingent consideration |
Total current liabilities |
1.7B |
DEFERRED INCOME TAXES |
310.76M |
ACQUISITION-RELATED CONTINGENT CONSIDERATION |
LONG-TERM DEBT, LESS CURRENT PORTION, NET |
3.32B |
OTHER LIABILITIES |
654.49M |
COMMITMENTS AND CONTINGENCIES (NOTE 12) |
0 |
STOCKHOLDERS' EQUITY: |
Common Stock, $0.01 par value; 350,000,000 shares authorized; 137,935,436 and 136,309,917 shares issued; 116,757,314 and 116,057,895 shares outstanding at June 30, 2011 and December 31, 2010, respectively |
1.44M |
Additional paid-in capital |
1.17B |
Retained earnings |
126.23M |
Accumulated other comprehensive loss |
-4.92M |
Treasury stock, 21,178,122 and 20,252,022 shares at June 30, 2011 and December 31, 2010, respectively |
-763.12M |
Total Endo Pharmaceuticals Holdings Inc. stockholders' equity |
526.02M |
Noncontrolling interests |
59.2M |
Total stockholders' equity |
585.22M |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
6.57B |